Literature DB >> 14502005

Envelope diversity, coreceptor usage and syncytium-inducing phenotype of HIV-1 variants in saliva and blood during primary infection.

Stephanie A Freel1, Susan A Fiscus, Christopher D Pilcher, Prema Menezes, Julieta Giner, Ericka Patrick, Jeffrey L Lennox, Charles B Hicks, Joseph J Eron, Diane C Shugars.   

Abstract

OBJECTIVE: To determine whether oral fluids can serve as a model for studying HIV-1 shedding, we compared the genetic diversity, coreceptor use, and syncytium-inducing (SI) phenotype of viral variants in saliva and blood during primary HIV-1 infection.
DESIGN: Observational cross-sectional cohort study.
METHODS: Blood plasma and saliva were sampled from 17 men early in primary HIV-1 infection. Viral diversity, predicted X4/R5 genotype and SI phenotype in samples were determined by heteroduplex tracking assays (HTAs) targeting the V1/V2 and V3 gp120 regions, sequence analyses and MT-2 cell assay.
RESULTS: Identical or very similar HTA banding and deduced amino acid sequence patterns in the V1/V2 and V3-encoding regions were observed between paired fluids of each subject. As assessed by V1/V2 HTA, 10 subjects had a single major viral variant and seven subjects exhibited multiple yet highly related variants. Two subjects had V1/V2 variants in blood that were identical to saliva but present in different relative abundances. A sexual transmission pair exhibited genetically dissimilar variants, suggesting transmission of a minor variant or rapid evolution during initial viremia. All subjects harbored R5 non-SI variants.
CONCLUSIONS: Relatively homogenous viral populations detected in plasma and saliva prior to seroconversion suggests that HIV-1 is disseminated to oral fluids early in infection and reflects the quasispecies in blood. These findings suggest that the oral cavity may serve as an easily accessible surrogate model for studying the dynamics of HIV-1 shedding at mucosal sites.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14502005     DOI: 10.1097/00002030-200309260-00003

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  10 in total

1.  Evolution and recombination of genes encoding HIV-1 drug resistance and tropism during antiretroviral therapy.

Authors:  Binshan Shi; Christina Kitchen; Barbara Weiser; Douglas Mayers; Brian Foley; Kimdar Kemal; Kathryn Anastos; Marc Suchard; Monica Parker; Cheryl Brunner; Harold Burger
Journal:  Virology       Date:  2010-05-08       Impact factor: 3.616

2.  A novel denaturing heteroduplex tracking assay for genotypic prediction of HIV-1 tropism.

Authors:  Binshan Shi; Barbara Weiser; Linda M Styer; Kimdar Kemal; Cheryl Brunner; Kathryn Anastos; Harold Burger
Journal:  J Virol Methods       Date:  2012-06-21       Impact factor: 2.014

3.  Oral and systemic health correlates of HIV-1 shedding in saliva.

Authors:  M Navazesh; R Mulligan; N Kono; S K S Kumar; M Nowicki; M Alves; W J Mack
Journal:  J Dent Res       Date:  2010-07-29       Impact factor: 6.116

4.  Characterization of SIV in the oral cavity and in vitro inhibition of SIV by rhesus macaque saliva.

Authors:  Jessica S Thomas; Nedra Lacour; Pamela A Kozlowski; Steve Nelson; Gregory J Bagby; Angela M Amedee
Journal:  AIDS Res Hum Retroviruses       Date:  2010-08       Impact factor: 2.205

5.  Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection.

Authors:  Simon D W Frost; Terri Wrin; Davey M Smith; Sergei L Kosakovsky Pond; Yang Liu; Ellen Paxinos; Colombe Chappey; Justin Galovich; Jeff Beauchaine; Christos J Petropoulos; Susan J Little; Douglas D Richman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-09       Impact factor: 11.205

6.  HIV-1 subtype C envelope characteristics associated with divergent rates of chronic disease progression.

Authors:  Derseree Archary; Michelle L Gordon; Taryn N Green; Hoosen M Coovadia; Philip J R Goulder; Thumbi Ndung'u
Journal:  Retrovirology       Date:  2010-11-04       Impact factor: 4.602

7.  Evolution of proviral gp120 over the first year of HIV-1 subtype C infection.

Authors:  Vladimir Novitsky; Stephen Lagakos; Michaela Herzig; Caitlin Bonney; Lemme Kebaabetswe; Raabya Rossenkhan; David Nkwe; Lauren Margolin; Rosemary Musonda; Sikhulile Moyo; Elias Woldegabriel; Erik van Widenfelt; Joseph Makhema; M Essex
Journal:  Virology       Date:  2008-10-29       Impact factor: 3.616

8.  Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals.

Authors:  M Kearney; F Maldarelli; W Shao; J B Margolick; E S Daar; J W Mellors; V Rao; J M Coffin; S Palmer
Journal:  J Virol       Date:  2008-12-30       Impact factor: 5.103

9.  Detection of HIV-1 in Saliva: Implications for Case-Identification, Clinical Monitoring and Surveillance for Drug Resistance.

Authors:  Maya Balamane; Mark A Winters; Sudeb C Dalai; Alexandra H Freeman; Mark W Traves; Dennis M Israelski; David A Katzenstein; Jeffrey D Klausner
Journal:  Open Virol J       Date:  2010-05-28

10.  A predominance of R5-like HIV genotypes in vaginal secretions is associated with elevated plasma HIV-1 RNA levels and the absence of anti-retroviral therapy.

Authors:  Tara C Randolph; Patricia J Kissinger; Rebecca A Clark; Nedra Lacour; Angela M Amedee
Journal:  Virol J       Date:  2008-07-29       Impact factor: 4.099

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.